Riskpilot← Back to searchSign inGet full accessBioscand Aktiebolag
ABActiveOrg 5561956557Rospiggsvägen 6Research and experimental development on natural sciences and engineering · NACE 7210Est. 19770 employees
Revenue 2024
SEK 0
EBITDA margin
—
+5% vs 2023
Equity ratio
96.9%
Financial strength
Net profit 2024
SEK -30K
+6% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -38K | +5% |
| Net profit | SEK -30K | +6% |
| Total assets | SEK 589K | -7% |
| Equity | SEK 571K | -5% |
| Employees | 0 | — |
Legal name
Bioscand Aktiebolag
Org number
5561956557
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 oktober 1977
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av Kronvall, Hans Carl Göran Kronvall, Ragnhild Elisabet
Company purpose
Bolaget skall bedriva medicinsk teknisk utveckling och medicinsk konsultverksamhet samt bedriva försäljning och utveckling av datorprogram och datorsystem samt därmed sammanhängande konsulttjänster ävensom idka annan därmed förenlig verksamhet.
Address
Rospiggsvägen 6
Phone
+46854440006
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −77 | −36 | −34 | −40 | −38 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −77 | −36 | −34 | −40 | −38 |
| Net financials | −1 | −1 | −1 | 8 | 7 |
| Profit before tax | −78 | −37 | −35 | −32 | −30 |
| Tax | −352 | −0 | −0 | −0 | −0 |
| Net profit | −430 | −37 | −35 | −32 | −30 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 086 | 1 024 | 666 | 632 | 589 |
| Equity | 704 | 667 | 632 | 601 | 571 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 382 | 357 | 34 | 32 | 18 |
| Total debt | 382 | 357 | 34 | 32 | 18 |
EBITDA margin
-3800000.0%
This company
15.8%
Market median
-24050733% vs market
20202024
Equity ratio
96.9%
This company
38.2%
Market median
+154% vs market
20202024
Return on equity
-5.3%
This company
18.4%
Market median
-129% vs market
20202024
Net profit margin
-3000000.0%
This company
8.1%
Market median
-37037137% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bioscand Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnhild Elisabet Kronvall | Deputy Board Member | 0 companies |
| Hans Carl Göran Kronvall | Board of Directors | 0 companies |